Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Teletherapy for deaf kids: a new way to bridge language gaps?

NCT ID NCT04928209

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether speech-language teletherapy can improve language outcomes in deaf or hard-of-hearing children aged 0-27 months. Researchers enrolled 210 children, some publicly insured and some privately insured, and gave some access to an 18-month teletherapy program. The goal was to see if teletherapy could help address language disparities.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
speech-language teletherapy
What this could lead to
If it works, this could provide a way to improve speech and language development in deaf or hard-of-hearing children, especially those with limited access to in-person therapy.
What could go wrong
This is a completed study, but results may not apply to all children or settings. Teletherapy may not be as effective as in-person care for some families.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

210 people

The number who actually took part.

Started

Jul 2021

Finished

Dec 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

0 to 27 months

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age 0-27 months; * Hearing loss, as determined by auditory brainstem response (ABR) or behavioral audiometry (average of pure-tone air-conduction hearing thresholds (0.5-4 kHz; PTA) calculated from at least 2 frequencies from ABR (dB eHL) or behavioral audiometry (dB HL)): * bilateral sensorineural, mixed, or permanent conductive hearing loss with better-ear PTA \> 20 dB. * single-sided deafness (unilateral SNHL with PTA \> 70 dB); * unilateral complete aural atresia; or * bilateral auditory-neuropathy spectrum disorder, as determined by ABR. * Primary home language is English or Spanish, determined by electronic medical record or direct parent report. * For children with PTA \> 20 dB, either: * Currently fit with hearing aid or using a cochlear implant; OR * Date identified for hearing-aid fitting or cochlear-implant activation within 3 months of enrollment. Exclusion Criteria: * Family does NOT have the intention to pursue listening and spoken language for their child, based on parent report; * Moderate to severe global developmental delay, as determined by managing audiologist and/or otolaryngologist, based on: * ICD-10 diagnosis code or chart review of medical progress notes indicating global developmental delay; * presence of syndrome known to be associated with this delay (such as Trisomy 21, 22q11 syndrome, or CHARGE syndrome); OR * parent report. * Speech-language teletherapy received through a clinical provider outside of this study at the time of enrollment, based on parent report. * No prognosis for access to sound as determined by managing audiologist and/or otolaryngologist. All children with bilateral severe-to-profound SNHL must have imaging to confirm this criterion prior to enrollment in the study. Children will be excluded if they have bilateral severe-to-profound sensorineural hearing loss and either: * Contraindication to cochlear implantation, OR * Temporal bone abnormalities that lead to great concern for poor cochlear-implant outcomes, including common cavity and/or cochlear nerve deficiency on imaging.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hearing loss are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Lucile Packard Children's Hospital Stanford

    Palo Alto, California, 94303, United States

  • Rady Children's Hospital - San Diego

    San Diego, California, 92123, United States

  • Seattle Children's Hospital

    Seattle, Washington, 98145, United States

  • The University of California - San Francisco

    San Francisco, California, 94158, United States

  • UCSF Benioff Children's Hospital - Oakland

    Oakland, California, 94609, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.